Progressive Supranuclear Palsy Clinical Trial
Official title:
tDCS Plus Physical Therapy for Progressive Supranuclear Palsy: a Double Blind Randomized Sham-controlled Study With Wearing Sensors Technology
| NCT number | NCT04237948 |
| Other study ID # | 19/02 |
| Secondary ID | |
| Status | Completed |
| Phase | N/A |
| First received | |
| Last updated | |
| Start date | January 1, 2018 |
| Est. completion date | December 15, 2019 |
| Verified date | January 2020 |
| Source | Fondazione Europea di Ricerca Biomedica Ferb Onlus |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Interventional |
Objective of the study:
To test the efficacy of cerebellar transcranial direct current stimulation (tDCS) associated
with physical rehabilitation on postural instability and falls in progressive supranuclear
palsy using a double-blind design and wearing sensors technology
Design:
Twenty probable PSP patients with no dementia and still able to walk will be recruited for a
randomized double-blind sham-controlled study. Each patient will be hospitalized for a four
week physical rehabilitation. In the real-arm, the patients will undergo a ten cerebellar
tDCS stimulations while the placebo arm will undergo sham stimulation.
Each patient will be evaluated before and after stimulation by PSP-rating scale (PSP-RS),
cognitive tests and a battery of gait and movement tests using wearing sensors technology.
| Status | Completed |
| Enrollment | 20 |
| Est. completion date | December 15, 2019 |
| Est. primary completion date | November 15, 2019 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | 40 Years to 85 Years |
| Eligibility |
Inclusion Criteria: probable PSP diagnosis ability to stand alone without support for at least 5 seconds ability to walk without aid for at least three meters Exclusion Criteria: dementia or behavioral alterations contraindications of stimulation |
| Country | Name | City | State |
|---|---|---|---|
| Italy | Parkinson's disease Rehabilitation Centre - FERB ONLUS | Trescore Balneario |
| Lead Sponsor | Collaborator |
|---|---|
| Fondazione Europea di Ricerca Biomedica Ferb Onlus | Università degli Studi di Brescia, University of Kiel |
Italy,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | PSP rating scale (PSP-RS) | Assessment of postural instability and disability of patients (scores ranging from 0 to 100, lower scores indicate less disability) | Changes from Baseline to immediately after stimulation and after 3 months | |
| Primary | Falls | Number of falls will be recorded using a diary | Number of falls recorded starting from immediately after stimulation until 3 months after the end of stimulation | |
| Primary | Cognitive testing | Total Z-scores of cognitive assessment (including eight tests assessing memory, executive function, attention and visual-spatial function) | Changes from Baseline to immediately after stimulation | |
| Primary | Static Balance- area of sway | The area of sway during the postural instability tasks will be assessed (unit of measure mm2) | Changes from Baseline to immediately after stimulation | |
| Secondary | Tinetti Balance test (TBT) | Assessment of postural instability (0-28, higher scores indicate better performances) | Changes from Baseline to immediately after stimulation and after 3 months | |
| Secondary | Static Balance: wearable sensor analyses - velocity | the velocity of sway will be assessed during the postural instability tasks (unit of measure (mm/s) | Changes from Baseline to immediately after stimulation | |
| Secondary | Gait speed | The speed of gait will be assessed in one minute of normal and dual-task walking | Changes from Baseline to immediately after stimulation | |
| Secondary | Turning speed | The velocity of turning will be assessed in timed up and go tests | Changes from Baseline to immediately after stimulation | |
| Secondary | Activity of daily living | the dependence of patient in ADL will be assessed with the help of caregiver | Changes from Baseline to immediately after stimulation |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04096651 -
Pathophysiology of Gait and Posture in Progressive Supranuclear Palsy
|
N/A | |
| Recruiting |
NCT02194816 -
Modifiable Variables in Parkinsonism (MVP)
|
||
| Completed |
NCT00703677 -
A Pilot Trial of Lithium in Subjects With Progressive Supranuclear Palsy or Corticobasal Degeneration
|
Phase 1/Phase 2 | |
| Completed |
NCT00382824 -
Effects of Coenzyme Q10 in Progressive Supranuclear Palsy (PSP)
|
N/A | |
| Completed |
NCT04184063 -
Study of NBMI Treatment in Patients With Atypical Parkinsons (PSP or MSA)
|
Phase 2 | |
| Recruiting |
NCT04706234 -
Systematic Assessment of Laryngopharyngeal Function in Patients With MSA, PD, and 4repeat Tauopathies
|
||
| Recruiting |
NCT04472130 -
Neurodegenerative Diseases Registry
|
||
| Recruiting |
NCT04139551 -
Oxford Study of Quantification in Parkinsonism
|
||
| Completed |
NCT02734485 -
Deep TMS for the Treatment of Patients With Parkinson's Disease and Progressive Supranuclear Palsy
|
N/A | |
| Completed |
NCT01110720 -
Study to Evaluate the Safety and Efficacy of Davunetide for the Treatment of Progressive Supranuclear Palsy
|
Phase 2/Phase 3 | |
| Completed |
NCT01174771 -
Repetitive Transcranial Magnetic Stimulation (TMS) for Progressive Supranuclear Palsy and Corticobasal Degeneration
|
N/A | |
| Completed |
NCT00465790 -
Research of Biomarkers in Parkinson Disease
|
Phase 0 | |
| Completed |
NCT02460094 -
Multiple Ascending Dose Study of Intravenously Administered BMS-986168 (BIIB092) in Patients With Progressive Supranuclear Palsy
|
Phase 1 | |
| Active, not recruiting |
NCT04993768 -
A Phase 2a Study of TPN-101 in Patients With Progressive Supranuclear Palsy (PSP)
|
Phase 2 | |
| Recruiting |
NCT03225144 -
Investigating Complex Neurodegenerative Disorders Related to Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
|
||
| Completed |
NCT03058965 -
Phase 0 Evaluation of [18F]MNI-958 as a Potential PET Radioligand for Imaging Tau Protein in the Brain
|
Early Phase 1 | |
| Recruiting |
NCT02605785 -
A Molecular Anatomic Imaging Analysis of Tau in Progressive Supranuclear Palsy
|
N/A | |
| Completed |
NCT01353183 -
Analysis of the Enteric Nervous System Using Colonic Biopsies
|
N/A | |
| Completed |
NCT00385710 -
Trial of Valproic Acid in Patients With Progressive Supranuclear Palsy (Depakine)
|
Phase 2 | |
| Recruiting |
NCT05260151 -
Tau Protein and SV2a Imaging in Patients With Tau Protein-related Diseases
|